← Back to Search

Other

BMX-010 for Rosacea

Phase 2
Waitlist Available
Research Sponsored by BioMimetix JV, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 43 days
Awards & highlights

Study Summary

This trial is testing a new drug for Rosacea, a skin condition. Up to 210 people will be enrolled.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~43 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 43 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine if BMX-010 cream or gel provides better efficacy in the treatment of rosacea.
Determine if BMX-010 cream or gel provides better efficacy in the treatment of the redness of rosacea.
Determine whether the optimum frequency of topical application of BMX-010 0.03% is once per day or twice per day for a treatment interval of up to 28 days.
+3 more
Secondary outcome measures
Assess the mean percent reduction change in inflammatory papules/pustules counts from baseline to end of study.
Document, as possible, the clinical effects of BMX-010 in subjects with Rosacea through clinical photography.

Trial Design

2Treatment groups
Experimental Treatment
Group I: BMX-010 0.1%Experimental Treatment1 Intervention
Approximately 30 subjects will receive BMX-010 0.1% for 7-28 days to be applied topically to Rosacea of the face.
Group II: BMX-010 0.03%Experimental Treatment1 Intervention
Approximately 30 subjects will receive BMX-010 0.03% for 7-28 days to be applied topically to Rosacea of the face.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BMX-010
2018
Completed Phase 2
~140

Find a Location

Who is running the clinical trial?

BioMimetix JV, LLCLead Sponsor
9 Previous Clinical Trials
610 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
2018. "Evaluation of Topical Application of BMX-010 in Subjects With Rosacea". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03756389.
~3 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top